Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration

Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 1998-08, Vol.32 (2), p.274-283
Hauptverfasser: Marschang, Harald, Schöls, Wolfgang, Karolyi, Laszlo, Beyer, Thorsten, Kübler, Wolfgang, Brachmann, Johannes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 283
container_issue 2
container_start_page 274
container_title Journal of cardiovascular pharmacology
container_volume 32
creator Marschang, Harald
Schöls, Wolfgang
Karolyi, Laszlo
Beyer, Thorsten
Kübler, Wolfgang
Brachmann, Johannes
description Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.
doi_str_mv 10.1097/00005344-199808000-00015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80062348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80062348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</originalsourceid><addsrcrecordid>eNp1UsFu1DAQtRCoLIVPQPIBcQs4sZONuaHtllYqUFE4WxNnrLp17GI7Kvtl_B4Ou-wNSyOPNe_NjN4zIbRm72om1-9ZOS0Xoqql7FlfXlWJun1CVnXLeSVYw5-SFas7VjVCdM_Ji5TuCkK06-6EnMg1Y1KyFfl9Zo3BiD5bcHRbcp0TDYaO1U3I4IKjwdObeUA_Bg1xXGDXc7y3_g7p513Qu4yJXqbgIONITQwT_RLiVGAhln1pDrQW9Ax2iV6HlK03EHW2pesGvPVILxBiTh_ot-Bwmbz9lSNodG52EAsnQ0p2nugmeF32jLCQX5JnBlzCV4f7lPw4337fXFRXXz9dbj5eVbotClVja7QesO0EH3nHmiJIrVvd65KDRC6LJCVQ4DA0XSM0ahAdl700bBxG4Kfk7b7vQww_Z0xZTTYty4HHMCdVpO8aLvoC7PdAHUNKEY16iHaCuFM1U4tn6p9n6uiZ-utZob4-zJiHCccj8WBSqb851CFpcCaC1zYdYY3g_VqKAhN72GNwGWO6d_MjRnWL4PKt-t-P4X8A4Dmwuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80062348</pqid></control><display><type>article</type><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</creator><creatorcontrib>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</creatorcontrib><description>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-199808000-00015</identifier><identifier>PMID: 9700990</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Action Potentials - drug effects ; Animals ; Anti-Arrhythmia Agents - pharmacology ; Biological and medical sciences ; Cardiovascular system ; Cells, Cultured ; Dogs ; Heart - drug effects ; Heart - physiology ; Medical sciences ; Miscellaneous ; Myocardial Infarction - pathology ; Myocardial Infarction - physiopathology ; Myocardium - metabolism ; Pharmacology. Drug treatments ; Potassium - physiology ; Purkinje Fibers - drug effects ; Purkinje Fibers - pathology ; Sotalol - pharmacology</subject><ispartof>Journal of cardiovascular pharmacology, 1998-08, Vol.32 (2), p.274-283</ispartof><rights>Lippincott-Raven Publishers</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</citedby><cites>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-199808000-00015$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00005344-199808000-00015$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>315,781,785,4610,27928,27929,64670,65465</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2438794$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9700990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marschang, Harald</creatorcontrib><creatorcontrib>Schöls, Wolfgang</creatorcontrib><creatorcontrib>Karolyi, Laszlo</creatorcontrib><creatorcontrib>Beyer, Thorsten</creatorcontrib><creatorcontrib>Kübler, Wolfgang</creatorcontrib><creatorcontrib>Brachmann, Johannes</creatorcontrib><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</description><subject>Action Potentials - drug effects</subject><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Cells, Cultured</subject><subject>Dogs</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardium - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - physiology</subject><subject>Purkinje Fibers - drug effects</subject><subject>Purkinje Fibers - pathology</subject><subject>Sotalol - pharmacology</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UsFu1DAQtRCoLIVPQPIBcQs4sZONuaHtllYqUFE4WxNnrLp17GI7Kvtl_B4Ou-wNSyOPNe_NjN4zIbRm72om1-9ZOS0Xoqql7FlfXlWJun1CVnXLeSVYw5-SFas7VjVCdM_Ji5TuCkK06-6EnMg1Y1KyFfl9Zo3BiD5bcHRbcp0TDYaO1U3I4IKjwdObeUA_Bg1xXGDXc7y3_g7p513Qu4yJXqbgIONITQwT_RLiVGAhln1pDrQW9Ax2iV6HlK03EHW2pesGvPVILxBiTh_ot-Bwmbz9lSNodG52EAsnQ0p2nugmeF32jLCQX5JnBlzCV4f7lPw4337fXFRXXz9dbj5eVbotClVja7QesO0EH3nHmiJIrVvd65KDRC6LJCVQ4DA0XSM0ahAdl700bBxG4Kfk7b7vQww_Z0xZTTYty4HHMCdVpO8aLvoC7PdAHUNKEY16iHaCuFM1U4tn6p9n6uiZ-utZob4-zJiHCccj8WBSqb851CFpcCaC1zYdYY3g_VqKAhN72GNwGWO6d_MjRnWL4PKt-t-P4X8A4Dmwuw</recordid><startdate>199808</startdate><enddate>199808</enddate><creator>Marschang, Harald</creator><creator>Schöls, Wolfgang</creator><creator>Karolyi, Laszlo</creator><creator>Beyer, Thorsten</creator><creator>Kübler, Wolfgang</creator><creator>Brachmann, Johannes</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199808</creationdate><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><author>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Action Potentials - drug effects</topic><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Cells, Cultured</topic><topic>Dogs</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardium - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - physiology</topic><topic>Purkinje Fibers - drug effects</topic><topic>Purkinje Fibers - pathology</topic><topic>Sotalol - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marschang, Harald</creatorcontrib><creatorcontrib>Schöls, Wolfgang</creatorcontrib><creatorcontrib>Karolyi, Laszlo</creatorcontrib><creatorcontrib>Beyer, Thorsten</creatorcontrib><creatorcontrib>Kübler, Wolfgang</creatorcontrib><creatorcontrib>Brachmann, Johannes</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marschang, Harald</au><au>Schöls, Wolfgang</au><au>Karolyi, Laszlo</au><au>Beyer, Thorsten</au><au>Kübler, Wolfgang</au><au>Brachmann, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1998-08</date><risdate>1998</risdate><volume>32</volume><issue>2</issue><spage>274</spage><epage>283</epage><pages>274-283</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>9700990</pmid><doi>10.1097/00005344-199808000-00015</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 1998-08, Vol.32 (2), p.274-283
issn 0160-2446
1533-4023
language eng
recordid cdi_proquest_miscellaneous_80062348
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Action Potentials - drug effects
Animals
Anti-Arrhythmia Agents - pharmacology
Biological and medical sciences
Cardiovascular system
Cells, Cultured
Dogs
Heart - drug effects
Heart - physiology
Medical sciences
Miscellaneous
Myocardial Infarction - pathology
Myocardial Infarction - physiopathology
Myocardium - metabolism
Pharmacology. Drug treatments
Potassium - physiology
Purkinje Fibers - drug effects
Purkinje Fibers - pathology
Sotalol - pharmacology
title Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T12%3A35%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Effects%20of%20d-Sotalol%20on%20Subendocardial%20Purkinje%20Myocytes%20Isolated%20from%20Normal%20or%2010%20to%2014%20Days%20Postinfarction%20Canine%20Hearts:%20Role%20of%20Extracellular%20Potassium%20Concentration&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Marschang,%20Harald&rft.date=1998-08&rft.volume=32&rft.issue=2&rft.spage=274&rft.epage=283&rft.pages=274-283&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-199808000-00015&rft_dat=%3Cproquest_cross%3E80062348%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80062348&rft_id=info:pmid/9700990&rfr_iscdi=true